Ogeda's Series B Round

Ogeda raised a round of funding on October 02, 2015.

Ogeda, fka Euroscreen, is a clinical-stage drug discovery company that discovers and develops small molecule drugs targeting G-protein coupled receptors (GPCRs).…

Articles about Ogeda's Series B Round: